Product Name |
N-Nitroso Atropine EP Impurity B |
Alternate Names |
Atropine Impurities, Impurities of Atropine |
CAT No. |
CS-EO-02299
|
CAS No. |
55855-45-3 |
Category |
Impurities |
Stock |
IN-Stock
|
Mol. Wt. |
304.3 g/mol |
Mol. For. |
C16H20N2O4
|
Hazardous |
This is not a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Atropine |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
N-Nitroso Atropine EP Impurity B is a chemical compound that is commonly used in pharmaceutical research and development laboratories. It is classified as an impurity of atropine, a medication that is used to treat a variety of medical conditions such as excessive sweating, bradycardia, and gastrointestinal disorders. N-Nitroso Atropine EP Impurity B is a byproduct of the synthesis of atropine and is often present as an impurity in atropine formulations.
Chemically, N-Nitroso Atropine EP Impurity B is a nitroso compound that has a molecular weight of 296.3 g/mol. It is a yellow to orange crystalline solid that is sparingly soluble in water but soluble in organic solvents such as methanol and ethanol. The impurity is known to be potentially harmful and may have adverse effects on human health.
In pharmaceutical research, N-Nitroso Atropine EP Impurity B is used as a reference standard to evaluate the purity of atropine formulations. It is also used in analytical methods to determine the concentration of atropine and its related impurities in pharmaceutical preparations. The impurity is a subject of regulatory scrutiny, and its levels in atropine formulations are strictly monitored to ensure the safety and efficacy of the medication.
In conclusion, N-Nitroso Atropine EP Impurity B is an important reference standard in pharmaceutical research and development. It is a potentially harmful impurity that is present in atropine formulations and is subject to strict regulatory scrutiny. Its usage and chemical information are vital in ensuring the safety and efficacy of atropine medications.